Evidence map›Paper›PMID 31941262›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2019

[Quantitative detection and clinical value of CD44 in patients with nonalcoholic fatty liver disease].

M Fang, M Yao, J L Yang, L Wang, J Y Sun, M N Wu, D F Yao, B J Tai

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
  3. [Mechanism of T lymphocyte subsets in the malignant transformation of non-alcoholic fatty liver disease].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

M FangCenter of Clinical Medicine, Affiliated Hospital of Nantong University, Jiangsu 226001, China; Medical School of Nantong University, Jiangsu 226001, China; Department of Infective Disease, Affiliated Hospital of Nantong University, Jiangsu 226001, China.
M YaoMedical School of Nantong University, Jiangsu 226001, China.
J L YangCenter of Clinical Medicine, Affiliated Hospital of Nantong University, Jiangsu 226001, China.
L WangMedical School of Nantong University, Jiangsu 226001, China.
J Y SunCenter of Clinical Medicine, Affiliated Hospital of Nantong University, Jiangsu 226001, China.
M N WuCenter of Clinical Medicine, Affiliated Hospital of Nantong University, Jiangsu 226001, China.
D F YaoCenter of Clinical Medicine, Affiliated Hospital of Nantong University, Jiangsu 226001, China.
B J TaiDepartment of Infective Disease, Affiliated Hospital of Nantong University, Jiangsu 226001, China.
Nantong University · CN

Funding

Jiangsu Projects of Medical Science BE2016698Nantong S & T Projects of China MS12017014-4National Natural Science Foundation of China 31872738, 81673241
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularCase-Control StudiesEnzyme-Linked Immunosorbent AssayHepatitis B, ChronicHumansHyaluronan ReceptorsLiver CirrhosisLiver Function TestsLiver NeoplasmsNon-alcoholic Fatty Liver DiseaseCD44 protein, humanHyaluronan ReceptorsFatty liver, alcoholicLiver diseasesSignal molecule

Identifiers

PMID31941262
PMCPMC12814123
OpenAlexW3010083645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.